Cargando…
Management disclosure of risk factors and COVID-19
Public companies in the United States are required to file annual reports (i.e., Form 10-K) and disclose, among other things, the risk factors that may harm their stock price. The risk of a pandemic was well-known before the recent crisis, and we now know that the initial impact on many shareholders...
Autores principales: | Loughran, Tim, McDonald, Bill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935242/ https://www.ncbi.nlm.nih.gov/pubmed/36811024 http://dx.doi.org/10.1186/s40854-023-00459-5 |
Ejemplares similares
-
Hedging Covid-19 risk with ESG disclosure
por: Jin, Yuqian, et al.
Publicado: (2023) -
Disclosure of funding sources and conflicts of interest in evidence underpinning vitamin D and calcium recommendations in bone health guidelines
por: Baram, Liora, et al.
Publicado: (2022) -
Association between maternal HIV disclosure and risk factors for perinatal transmission
por: Yee, Lynn M, et al.
Publicado: (2018) -
Public responses to COVID‐19 case disclosure and their spatial implications
por: Lee, Kwan Ok, et al.
Publicado: (2021) -
Information disclosure of COVID-19 specific medicine and stock price crash risk in China
por: Duan, Jiangjiao, et al.
Publicado: (2022)